ArticleFrontiers in medicine2026
Axillary vein thrombosis related to midline catheter in a patient with Wilson's disease: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wilson's disease (WD) is a rare hereditary disorder of copper metabolism that requires long-term copper-chelating therapy. In China, cyclic intravenous sodium dimercaptopropanesulfonate (DMPS) is used in hospitalized patients to enhance copper excretion, whereas oral chelating agents are typically used for maintenance therapy. We report a 44-year-old woman with WD complicated by liver cirrhosis and prior splenectomy who developed left axillary vein thrombosis six days after midline catheter placement for intravenous DMPS infusion. Baseline evaluation showed WD-related hepatic and neurological involvement, with normal conventional coagulation parameters but evidence of platelet activation. Duplex ultrasound confirmed axillary vein thrombosis. The patient was treated with oral rivaroxaban for 3 months, resulting in complete symptom resolution. Follow-up ultrasound suggested recanalization of the affected vein, and no recurrence of thrombotic events occurred during 6 months of follow-up. This case highlights a potential risk of catheter-related thrombosis in WD patients with additional prothrombotic factors and underscores the importance of careful venous access management during inpatient intravenous therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.